Recruiting
Phase 2

TRIV-573

Sponsor:

Triveni Bio

Code:

NCT07782333

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TRIV-573

Placebo

Study Details

Brief summary:

The goal of this interventional study is to learn if TRIV-573 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-573.

Participants will receive 5 doses of the study intervention that they are randomized to (TRIV-573 or placebo).

The study duration for individual participants is up to 40 weeks, including a Screening period of up to 30 days.

Conditions

Atopic Dermatitis

Study ID

NCT07782333

Start date

Sep 9, 2026

Status verified date

Oct, 2026

Completion date

Feb, 2028

Anticipated

Primary completion date

Aug, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Has Atopic Dermatitis.
  • Has moderate to severe, active and symptomatic atopic dermatitis.

Exclusion Criteria:

  • Severe or uncontrolled medical conditions.
  • Use of prohibited medications within stated washout periods.

Study Design

Enrollment

90 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: TRIV-573

placebo comparator: Placebo

Interventions

TRIV-573

TRIV-573 (Subcutaneous injection)

Placebo

Placebo (Matching Placebo subcutaneous injection)

Primary outcome measure

  • Percentage of participants with improvement of AD [ Time Frame: Baseline through Week 16 ]

Central Contacts and Locations

Central contacts

Locations

Triveni Bio Site #15

Recruiting

Fountain Valley, California, United States, 92708

Contacts

Triveni Bio Site #4

Recruiting

Los Angeles, California, United States, 90045

Contacts

Triveni Bio Site #11

Recruiting

Boca Raton, Florida, United States, 33486

Contacts

Triveni Bio Site #7

Recruiting

Miami, Florida, United States, 33126

Contacts

Triveni Bio Site #3

Recruiting

Miami, Florida, United States, 33142

Contacts

Triveni Bio Site #2

Recruiting

Indianapolis, Indiana, United States, 46250

Contacts

Triveni Bio Site #13

Recruiting

Bay City, Michigan, United States, 48706

Contacts

Triveni Bio Site #16

Recruiting

Boardman, Ohio, United States, 44512

Contacts

Triveni Bio Site #1

Recruiting

Camp Hill, Pennsylvania, United States, 17011

Contacts

Triveni Bio Site #14

Recruiting

Myrtle Beach, South Carolina, United States, 29588

Contacts

Triveni Bio Site #9

Recruiting

San Antonio, Texas, United States, 78213

Contacts

Triveni Bio Site #6

Recruiting

San Antonio, Texas, United States, 78218

Contacts

Triveni Bio Site #8

Recruiting

Spokane, Washington, United States, 99202

Contacts

Triveni Bio Site #17

Recruiting

Calgary, Alberta, Canada, T2W4X9

Contacts

Triveni Bio Site #5

Recruiting

Barrie, Ontario, Canada, L4M7G1

Contacts

More Information

Sponsor

Triveni Bio

Last update posted

Oct 28, 2026

Last verified

Oct, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-29. This information was provided to ClinicalTrials.gov by Triveni Bio on 2026-10-28. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.